NIH study identified features of Long COVID neurological symptoms
On May 5, 2023, the National Institutes of Health reported that a study had identified features of Long…
Fred Hutchinson Cancer Center received $78 million gift to support precision oncology
On Sept. 8, 2022, the Fred Hutchinson Cancer Center (FHCRC) announced that Stuart and Molly Sloan had pledged…
Biotechnology | COVID-19 | Disease | Life Science News | Medicine | NIH | Therapeutics
La Jolla Institute for Immunology awarded $1.4 million to study COVID-19 in Latino Americans
On Oct. 8, 2020, the La Jolla Institute for Immunology (LJI) announced it had been granted $1.4 million…
Persistent immune memory of COVID-19 found in recovered patient T cells
On Sept. 4, 2020, the University of Oxford researchers have found that natural infection with COVID-19 produces a…
Persistent immune memory of COVID-19 found in recovered patient T cells
On Sept. 4, 2020, the University of Oxford researchers found that natural infection with COVID-19 produces a robust…
Cancer Research Institute awarded $302 million in grants and fellowships
On Aug. 5, 2020, the Cancer Research Institute (CRI), a U.S. nonprofit organization dedicated to the discovery and…
Tonix Pharma announced plans for Massachusetts R&D facility to accelerate clinical development of vaccines and protein-based therapeutics
On Jul. 7, 2020, Tonix Pharmaceuticals announced its intent to purchase an approximately 40,000 square foot facility in…
Keck Foundation gifted $4 million to USC to speed public health and research on COVID-19
On Apr. 24, 2020, the W. M. Keck Foundation announced a $4 million gift that will help scientists…
Adaptive Biotechnologies and Amgen announced collaboration to address COVID-19 pandemic
On Apr. 2, 2020, Amgen and Adaptive Biotechnologies announced a collaboration aimed at helping address the COVID-19 pandemic….
Amgen and Adaptive Biotechnologies to develop a therapeutic to prevent or treat COVID-19
On Apr. 2, 2020, Amgen and Adaptive Biotechnologies announced a collaboration aimed at helping address the COVID-19 pandemic….
Mount Sinai developing an ‘end-to-end’ diagnostics solution for COVID-19
On Mar. 23, 2020, an expert team of researchers and clinicians in microbiology, virology, pathology, molecular science, and…
Mount Sinai and Harbour BioMed collaborated to advance treatment of cancer and Coronavirus COVID-19
On Mar. 6, 2020, Mount Sinai Health System and Harbour BioMed (HBM) announced a multi-year, multifaceted collaboration to…
Biotechnology | Infectious Disease | Life Science News | NIH | Non-Profit Research | Therapeutics | Vaccine
Seattle Children’s received $30 million NIH funding to establish centers for TB vaccine development
On Sept. 26, 2019, Seattle Children’s announced it was one of three recipients of $30 million in first-year-funding…
Alan Aderem, PhD, became president of Seattle BioMed – only the second in its more than 35-year history
On Jan. 1, 2012 Alan Aderem, Ph.D., became president of Seattle BioMed, now known as Center for Infectious…
William Hagopian at the Pacific Northwest Research Institute began Phase I of the hOKT3 study
In 2003, Dr. William Hagopian at the Pacific Northwest Research Institute began Phase I of the hOKT3 study….
The Stanford Hospital Center for Clinical Sciences Research building opened
In 2000, the Center for Clinical Sciences Research building opened, and is an example of a fully integrated…
The University of Michigan Rogel Cancer Center received Comprehensive NCI designation
In 1991, the University of Michigan Rogel Cancer Center received National Cancer Institute (NCI) comprehensive center designation. The…
Yale Cancer Center oncologists performed the first bone marrow transplant in Connecticut
In 1988, oncologists from Yale Cancer Center performed the first bone marrow transplant in Connecticut at the Yale-New…
The University of Michigan Cancer Center received NCI designation
In 1986, the University of Michigan Cancer Center received National Cancer Institute (NCI) designation. The Rogel Cancer Center…
Dr. Tak Wah Mak co-discovered the T-cell receptor and the gene that produces it
In 1983, Dr. Tak Wah Mak co-discovered the T-cell receptor and the gene that produces it. Dr. Mak…
Multiple research programs at the Scripps Clinic and Research Foundation drawn together into the Research Institute of Scripps Clinic
In 1977, the multiple research programs that had developed were formally drawn together into the Research Institute of…
The La Jolla Cancer Research Foundation, now the Sanford Burnham Prebys Medical Discovery Institute was founded
On Jul. 7, 1976 , the La Jolla Cancer Research Foundation, now the Sanford Burnham Prebys Medical Discovery…
Interleukin-2 was discovered
In 1976, interleukin-2 was discovered and purified which allowed researchers to grow T-cells and study their immunology, which…
Physician and researcher Edmund Keeney became director of the Scripps Metabolic Clinic
In 1955, physician and researcher Edmund Keeney became director of the Scripps Metabolic Clinic after Sherrillï¾’s death. That…
The Scripps Metabolic Clinic West Annex was completed in downtown La Jolla
In 1955, the Scripps Metabolic Clinic West Annex was completed in downtown La Jolla to house divisions of…
Dr. Jonas Salk was recruited to the University of Pittsburgh School of Medicine
In 1947, Dr. Jonas Salk was recruited from the University of Michigan by Dr. William S. McEllroy, dean…
The term ‘immunology’ first appeared
In 1902, the term ‘immunology’ first appeared in scientific communications, in relation to Paul Ehrlich’s work on the…